Empresa Vicore Pharma Holding AB Nasdaq Stockholm
Acciones
Biotecnología e investigación médica
Precio de cierre
Otros sitios de cotización
|
||
- SEK | - |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ahmed Mousa
CEO | Chief Executive Officer | 40 | 09/09/23 |
Hans Jeppsson
DFI | Director of Finance/CFO | - | 01/01/17 |
Elin Rosendahl
CTO | Chief Tech/Sci/R&D Officer | - | 16/11/20 |
Nina Carlén
ADM | Chief Administrative Officer | - | 01/12/09 |
Bertil Lindmark
CTO | Chief Tech/Sci/R&D Officer | 68 | 01/01 |
Johan Raud
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/18 |
Mikael Nygård
PRN | Corporate Officer/Principal | - | - |
Åsa Magnusson
PRN | Corporate Officer/Principal | - | - |
Jessica Shull
PRN | Corporate Officer/Principal | - | 01/01/21 |
Johanna Gräns
PRN | Corporate Officer/Principal | - | 01/06/15 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 57 | 01/01/18 | |
Chairman | 66 | 01/01/18 | |
Michael Buschle
BRD | Director/Board Member | 64 | 01/01/23 |
Heidi Hunter
BRD | Director/Board Member | 66 | 01/01/20 |
Director/Board Member | 63 | 01/01/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 111 722 979 | 96 099 394 ( 86,02 %) | 0 | 86,02 % |
Información de la empresa
Vicore Pharma Holding AB
Kornhamnstorg 53
111 27, Stockholm
+46 3 17 88 05 60
http://www.vicorepharma.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+12,30 % | 118 mil M | |
+12,15 % | 106 mil M | |
-8,14 % | 23,4 mil M | |
-1,69 % | 21,78 mil M | |
-10,60 % | 18,09 mil M | |
-41,25 % | 16,72 mil M | |
-15,33 % | 15,97 mil M | |
+5,80 % | 14,03 mil M | |
+28,03 % | 11,67 mil M |
- Bolsa de valores
- Acciones
- Acción VICO
- Acción
- Empresa Vicore Pharma Holding AB